Shares of Health Care sector company ACADIA Pharmaceuticals moved -1.1% today, and are now trading at a price of $28.32. The mid-cap stock's daily volume was 133,008 compared to its average volume of 1,642,282. The S&P 500 index returned a -0.0% performance.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization innovative medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. The company is based in San Diego and has 540 full time employees. Its market capitalization is $4,832,864,768.
15 analysts are following ACADIA Pharmaceuticals and have set target prices ranging from $13.0 to $42.0 per share. On average, they have given the company a rating of buy. At today's prices, ACAD is trading -9.03% away from its average analyst target price of $31.13 per share.
Over the last year, ACAD's share price has increased by 68.0%, which represents a difference of 61.0% when compared to the S&P 500. The stock's 52 week high is $33.99 per share whereas its 52 week low is $13.73.
| Date Reported | Cash Flow from Operations ($ k) | Capital expenditures ($ k) | Free Cash Flow ($ k) |
|---|---|---|---|
| 2023-02-28 | -114,035 | n/a | n/a |
| 2022-03-01 | -125,660 | -1,122 | -124,538 |
| 2021-02-25 | -136,166 | -7,587 | -128,579 |
| 2020-02-27 | -151,130 | -1,129 | -150,001 |
| 2019-02-27 | -167,470 | -2,104 | -165,366 |
| 2018-02-27 | -217,757 | -812 | -216,945 |
